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Cancer cells often encounter an environment of metabolic stress, including 
nutrient deprivation, low oxygen levels, or both. Cells respond to these and other types of 
stress, in part by using the physiological mechanism of autophagy. Autophagy is a type of 
“self-eating”, where organelles and macromolecules are recycled for use by cells for 
simple molecules and energy. While autophagy is recognized to be critical for survival of 
cancer cells in many situations, the mechanisms contributing to cell survival during 
glucose deprivation are incompletely understood. In order to enhance the treatment of 
cancer, the potential survival and signaling pathways important in the microenvironment 
of a tumor need to be elucidated.  
The goal of this thesis was to understand the role of autophagy and nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2) as mechanisms of cell survival in both glucose 
deprivation and hypoxia. Likewise, the role of glucose deprivation and autophagy on 
human epidermal growth factor receptor 2 (HER2) and estrogen receptor (ER) in breast 
cancer and response to targeted drug therapies was studied. Using pharmacological and 
genetic inhibition of both key autophagy proteins and Nrf2, we show that autophagy and 
Nrf2 signaling are important for the survival of cells exposed to glucose deprivation. 
However, these two survival pathways appear to be activated independently of one 
another. Nrf2 was also shown to affect survival in hypoxia. In unrelated studies to Nrf2, 
both estrogen and human epidermal growth factor receptors were discovered to be 
downregulated in response to glucose deprivation perhaps through a translational 
mechanism. Despite this downregulation of ER in MCF7 and T47D cells,        
 iii 
4-hydroxytamoxifen was still efficacious. All of these studies were conducted to obtain a 
better understanding of how the microenvironment of a tumor can affect the survival of 
cells and their response to therapies in order to target these survival pathways and 
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Chapter 1: Introduction 
Cancer cells often encounter an environment of metabolic stress, including 
nutrient deprivation, low oxygen levels, or both. Cells respond to these and other types of 
stress, in part by using the physiological mechanism of autophagy. Autophagy is a type of 
“self-eating”, where organelles and macromolecules are recycled for use by cells for 
simple molecules and energy. While autophagy is recognized to be critical for survival of 
cancer cells in many situations, the mechanisms contributing to cell survival during 
glucose deprivation are incompletely understood. In order to enhance the treatment of 
cancer, the potential survival and signaling pathways important in the microenvironment 
of a tumor need to be elucidated.  
This thesis will describe experimental work investigating mechanisms of cell 
survival during glucose deprivation, particularly focusing on the role of autophagy and of 
Nuclear Factor erythroid derived –like 2 (Nrf2) pathway. In addition to these pathways, 
glucose deprivation in relation to hypoxia and important signaling pathways in breast 
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2.1 Role of autophagy in normal physiology 
 
Autophagy (and more specifically macroautophagy) is a term that literally means 
“self-eating”. Autophagy is a physiologic process where a double-membraned 
autophagosome forms around organelles or macromolecules in the cytoplasm and fuses 
with a lysosome, leading to lysosomal contents being degraded into small molecules that 
can be used by the cell to sustain itself (1). Autophagy is critical for removing damaged 
organelles and macromolecules, as well as for generating energy and new substrates for 
biosynthesis when the cellular environment is insufficient in providing such substrates. 
Most likely because of the importance of autophagy in recycling defective organelles and 
preventing accumulation of aggregated proteins, this process occurs in normal cells at a 
basal level acting as a housekeeping function, and cancer cells appear to have a variably 
increased dependence on autophagy, possibly due to cancer cells having a greater level of 
metabolic stress (1-3). This importance of autophagy during nutrient deprivation was 
demonstrated by experiments showing that neonatal mice deficient in ATG7 or ATG5,  
key proteins in the pathway, die one day after birth, presumably due to lack of amino 
acids that autophagy would normally have maintained during the postpartum period 
before pups are able to obtain nutrients through nursing (4, 5). Moreover, this need for 
autophagy to provide nutrients during a time of inadequate supply is seen in many other 
circumstances. 
In cells deficient in ability to undergo apoptosis, autophagy is induced in order to 
maintain nutrients and ATP levels when growth factors are scarce. Inhibition of 
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autophagy leads to death of these cells unless growth factors are reintroduced, in which 
case proliferation can be resumed (6). For example, in cardiomyocytes it was found that 
during glucose deprivation, hexokinase II, an enzyme in the first step of glycolysis, binds 
to and inhibits mTORC1, thus inducing autophagy (7). Breast cells undergoing 
extracellular matrix detachment also induce autophagy in order to survive, and without 
autophagy, these cells undergo apoptosis (8). Autophagy is thought to be important in all 
cells of the body for maintaining homeostasis as well as for allowing survival during 
metabolic stress. 
 
2.2 Role of autophagy in cancer/ Paradox of tumor suppression 
vs tumor cell survival 
 
Over 80 years ago, Otto Warburg described a phenomenon whereby cancer cells 
metabolize glucose through glycolysis to pyruvate and lactate, foregoing the oxidation of 
pyruvate in mitochondria, even in the presence of adequate oxygen for the process of 
oxidative phosphorylation.  This process of anaerobic glycolysis is less efficient for 
generating ATP than oxidative phosphorylation.  With the high demand for glucose, 
cancer cells commonly have correspondingly increased levels of glucose transporters on 
the cell membrane (9), but any deficiency in the availability of exogenous glucose 
requires the recycling of endogenous, sources of energy, a demand that can be met by 
autophagy. As expected, autophagy appears to be particularly prevalent in tumor regions 
distant from blood vessels, which are presumed to have metabolic stress (10). Tumor cell 
autophagy, which commonly results from inadequate blood supply, parallels the 
responses seen in normal cells encountering similar stresses, with a lysosomal 
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degradation pathway activated by starvation, hypoxia, or growth factor deprivation (2). In 
the acidic environment, found in tumors due to the Warburg effect, lactate and other 
acidic metabolites cause upregulation of phosphorylated AMPK leading to decreased 
mTOR signaling and activation of autophagy. This process has been shown to protect 
melanoma cells (11). Autophagy can also be a mechanism for cell death, and, prolonged 
hypoxia in a variety of apoptosis-competent cell lines was found to induce autophagic 
cell death (12).  
The exact role of autophagy in cancer appears to be complex, depending on 
factors that include the context, type and stage of the tumor. Some studies have suggested 
that autophagy has a suppressive role during tumor initiation. Evidence to support this 
role include findings that Beclin 1, a protein involved in induction of autophagy, is a 
haploinsufficient tumor suppressor in breast cancer (13-16). In clinical tissue samples of 
breast cancer, Liang et al. observed that all adjacent normal tissues stained for Beclin 1, 
but over half of the tumors showed a decrease in Beclin 1 expression (14). Interestingly, 
induced expression of Beclin 1 in MCF7 breast cancer cells results in a less malignant 
phenotype and slower proliferation (14). Clearly the absence of important autophagic 
proteins  results in defective autophagy with these cells having more DNA double strand 
breaks, gene amplifications, and damaged mitochondria, along with p62 accumulation 
which cause an increase in reactive oxygen species (ROS) (15, 17). When autophagy is 
available to limit levels of ROS, suppression of tumorigenesis in immortalized baby 
mouse kidney cells expressing activated RAS occurs, and by limiting necrosis in 
apoptosis-deficient cells, inflammatory cells that would infiltrate the tumor and promote 
tumor growth are quelled (15). Thus, in some situations, autophagy appears to prevent 
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tumorigenesis through clearance of damaged organelles, maintaining energy homeostasis, 
and limiting genome damage (2).  
In other settings, however, autophagy appears to be important for cancer cell 
survival. For example, during hypoxia the HIF1α transcription factor induces BNIP3L, 
causing disruption of the Beclin1-Bcl2 complex and release of Beclin 1, thus inducing 
autophagy (2, 12). In this setting, autophagy provides nutrients to the tumor facing an 
increased metabolic demand, and is thus a survival response. In tumors, 
chemotherapeutic drugs also contribute to metabolic stress, and activation of autophagy 
in this setting can cause resistance to the chemotherapy. Supporting this concept are 
findings that inhibiting autophagy during chemotherapy may limit resistance to the drugs 
(18). Autophagy is also believed to be involved in dormancy during metabolic stress, and 
when nutrients become plentiful again, the cell can resume proliferation (2). Similarly, 
autophagy is thought to be important for resistance to anoikis, and thus may provide a 
mechanism for survival during metastasis (8, 15). As can be seen by the examples above, 
there is evidence for both a tumor-promoting and tumor-preventing role of autophagy. 
 
2.3 Molecular mechanisms of autophagy  
 
Autophagy is regulated by over 32 autophagy-specific proteins and involves 
multiple energy and nutrient sensing pathways, including AMPK, PI3K, HIF1, and 
mTOR. The mTOR pathway involves mTORC1, which is sensitive to the availability of 
nutrients. mTORC1 interacts with Raptor to directly phosphorylate p70S6K and 4E-BP1, 
which in turn regulate protein synthesis. Another pathway used by the cell to monitor its 
metabolic status is AMPK. AMPK is considered to be an energy sensor of the cell, 
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monitoring the AMP: ATP ratio and phosphorylating the protein, Raptor, when activated 
by relatively increased levels of AMP that occur in situations of low nutrients or 
metabolic stress. Phosphorylated Raptor, in turn, inhibits mTORC1 (or directly 
phosphorylates ULK1 and ULK2), blocking anabolic processes and initiating autophagy 
(18-21). Moruno, et al. interestingly found that addition of glucose to cells after a period 
of starvation can also induce autophagy, although this induction occurs through the 
MAPK pathway and not AMPK (21). MAPK family member, JNK, phosphorylates Bcl2, 
interrupting its complex with Beclin1 and inducing autophagy (18, 22). Notably, Bcl2 
can be both anti-apoptotic and anti- autophagic, with inhibition of autophagy resulting 
from its binding to Beclin1’s BH3 domain (13).  Ras mutations in cancer can also 
activate the ERK pathway, which inhibits mTORC1, or p38 can trigger AMPK, both of 
which lead to induction of autophagy (18). AMPK is apparently important in MEK/ERK 
regulation of autophagy, as it was shown that defective AMPK could no longer 
phosphorylate and activate MEK to upregulate autophagy. Also when MEK and ERK are 
inhibited Beclin 1 expression decreases and autophagy is downregulated (23). 
Additionally, the PI3K pathway can suppress autophagy through activating AKT which 
inhibits the TSC1/TSC2 complex, de-repressing mTORC1 (18). 
Under nutrient rich conditions, mTOR, Unc-51-like Kinase 1 (ULK1), Unc-51-
like Kinase 2 (ULK2), ATG13 and focal adhesion kinase family-interacting protein of 
200kD (FIP200) form a complex, wherein mTORC1 binds to ULK1 through Raptor, and 
through subsequent phosphorylation of the ULKs prevents induction of autophagy (3, 
24). During nutrient starvation, mTORC1 dissociates from ULKs resulting in their 
dephosphorylation and activation to then phosphorylate ATG13 and FIP200 (3, 24, 25). 
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Induction, the first step of autophagy occurs when starvation or treatment with an mTOR 
inhibitor, such as rapamycin, causes ULK1 and ULK2 to form a complex with FIP200 
and ATG13 (24, 25).  
The second step of autophagy, nucleation, begins when Beclin 1 recruits vps34 to 
a complex that also consists of p150 (3, 26, 27). Next, vesicle elongation occurs when 
ATG12 and ATG5 are covalently linked by ATG7 and ATG10, E1 and E2-like proteins 
respectively (3, 24, 25, 27). The ATG12-ATG5 complex then binds with ATG16L to 
form the preautophagosomal structure (3, 24, 25, 27). LC3 is cleaved by ATG4 at its 
carboxyl terminal to generate LC31, which is conjugated to a phosphatidylethanolamine 
by ATG7 and ATG3 to form LC3II (3, 24, 25, 27). The ATG12 complex assists in the 
conversion of soluble LC3I to membrane bound LC3II, the form found on mature 
autophagosomes, until the autophagosome fuses with a lysosome and degrades releasing 
its contents into the cytoplasm where they can be used for metabolism and synthesis of 
new proteins (3, 24, 25, 27). Nucleosides generated can be used to make ATP or 
converted to glucose using the pentose phosphate pathway (PPP). Amino acids can be 
shuttled into various points of the tricarboxylic acid cycle (TCA) (3). 
Autophagy is for the most part non-selective, but there is a molecular mechanism 
for cargo recognition (16, 25). Cargo selectivity involves ubiquitinated, aggregated 
proteins that need to be cleared from the cell. P62/SQSTM1 binds to these poly-
ubiquitinated substrates via an ubiquitin associated domain, linking the cargo to 
microtubule associated protein light chain 3 (LC3) on the outside of the autophagosome 
(25). Out of all the stages, the formation of the autophagosome and the blocking of 




Figure 2.1 Autophagic Process, adapted from “Methods in Mammalian Autophagy” 
(28) 
 
2.4 Measuring molecular events in autophagy  
 
There are several methods used to measure autophagy, including both steady-state 
methods and flux measurements. Steady-state methods that detect induction of autophagy 
include electron microscopy, immunoblotting to measure upregulation of LC3II, and 
fluorescence microscopy to monitor autophagosome formation. While measuring 
induction of autophagy is important, measurements of autophagy flux are even more 
informative for determining whether the process is being completed.  Methods to assess 
completion of autophagy include measuring the turnover of the LC3II protein, monitoring 
GFP-LC3, measurements of the p62 protein, and microscopy to monitor 
autophagosomes.  Autophagy can also be probed by disrupting the process with 
xenobiotics, including acidotropic dyes and inhibitors of autophagy (29). However, it is 
important to be aware of limitations to use of chemical inhibitors, since these agents can 
have non-specific effects; therefore, their use should be supplemented with genetic 
modification or blockage of the pathway (30). 
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Molecular assays are used for more quantitative assessment of the process. During 
autophagy, LC3I gets conjugated with phosphatidylethanolamine to form LC3II. LC3II 
migrates faster on a gel due to its greater hydrophobicity and thus the two bands of LC3 
can be separated from each other by electrophoresis. When measuring these forms of 
LC3, one should normalize to a loading control rather than LC3I, due to the instability of 
LC3I and the different affinity some antibodies have for LC3I. To assess flux, 
comparable samples can be treated with an autophagic inhibitor followed by 
measurements of LC3II or p62.  P62, a protein that brings cargo to the autophagosome, is 
used to indicate a block in autophagy and reduced turnover of ubiquitinated proteins (29, 
30). Increased p62 or LC3II observed in a sample treated with an autophagy inhibitor 
compared to a non- inhibitor treated sample is indicative of the autophagic process going 
to completion and degrading the contents of the autophagosome, as opposed to being 
blocked at an upstream step. There are many ways to measure autophagy and multiple 
methods should be used to ensure robust data. 
2.5 Evidence for a potential role of Nrf2 in cell survival during 
autophagy  
 
As discussed above, autophagy can be a mechanism of cell death as well as a 
mechanism for cell survival, particularly during cell stress.  One molecular pathway that 
we have found to be important for cell survival during glucose deprivation and 
potentially during autophagy is the Nrf2 (nuclear factor erythroid derived –like 2) 
pathway.  Autophagy and the Nrf2 pathway have previously been shown to be connected 
through the protein p62. P62 facilitates degradation of ubiquitinated proteins through 
autophagy using an ubiquitin binding domain on the c-terminal and LC3 interacting 
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region (31). mTOR, which inhibits autophagy, directly phosphorylates p62 on S351, 
causing a strong affinity for Keap1 (32) and thus increased Nrf2 activation. 
Accordingly, Nrf2 target gene expression has been shown to be suppressed during 
treatment with rapamycin, an mTOR inhibitor that also decreases p62 phosphorylation 
(32). Experiments involving ATG7 deficient cells and mice have found that autophagy 
leads to increased accumulation of p62, co-localization of p62 and Keap1 and induction 
of Nrf2 (32-34). Autophagy is important for tumor growth in these mice, and while 
ATG7 deficient mice show increased early tumor growth, growth of tumors later slows 
down due to poor mitochondrial function and metabolic deficiencies in tumor cells. Mice 
deficient in Nrf2 also show increased early tumor growth but increased survival of mice 
due to slow tumor growth later.  Initially, elevated ROS production is most likely 
beneficial for early tumor growth, but ROS appears to not be involved in the slower 
growth later in tumor development and reduced tumor burden seen in ATG7- or Nrf2-
deficient mice, compared to controls (34)  Interestingly, arsenic upregulates the quantity 
of autophagosomes through inhibition of fusion with the lysosome and acidification. 
Arsenic, like the ATG7 knockout mice, causes p62 accumulation leading to sequestration 
of Keap1 and activation of Nrf2. In this case, the activation of Nrf2 was due to p62 
accumulation rather than increased ROS.  
The role of reactive oxygen species (ROS) in autophagy and effects of ROS on 
tumor growth have been studied by other investigators.  It was shown by Wang, et al. that 
treatment of PC12 cells with melamine results in increased ROS, but the autophagic 
response helps to inhibit the excessive production of ROS (35). Autophagy is thought to 
be protective by preventing accumulation of ROS that may damage proteins or DNA 
 12 
(36), and cells deficient in the ATG7 gene have higher levels of ROS (37). Autophagy 
might be particularly important for the regulation of ROS in cancers with RAS mutations, 
where autophagy is needed by the cell to tolerate the extra mitochondrial and metabolic 
stress (36).  
ROS produced from mitochondria during oxidative phosphorylation can also 
indirectly regulate autophagy induction through AMPK (36) , and blocking ROS can 
result in decreased autophagy associated with decreased AMPK activation (38). Another 
clue for how ROS can induce autophagy comes from experiments showing that hydrogen 
peroxide can directly oxidize ATG4, leading to increased formation of LC3II.   Other 
work has found that with knock down of Nrf2, autophagy increases in order to deal with 
the reactive oxygen species, however, when Nrf2 is present at high levels, less autophagy 
is needed because of the ability of Nrf2 to defend the cell from ROS on its own (39).  
Sestrins are another group of autophagy-related proteins involved in the defense 
against ROS. The Nrf2 pathway also mediates the defenses of sestrins, and increases in 
either SESN1 or SESN2 reduce Keap1 protein and upregulates Nrf2. Blocking autophagy 
through chloroquine treatment results in an attenuated reduction of Keap1 by SESN2, 
suggesting that autophagy plays a role in decreasing Keap1expression level (40). While 
sestrins, AMPK, and other autophagy genes have a direct effect on Nrf2, overall 
metabolism has an effect on the oxidative state of the cell affecting its survival.  
Cancer cells have been shown to survive far worse in nutrient poor conditions 
than what is needed for survival of normal cells. This relative inability of cancer cells to 
survive nutrient poor conditions may be due to their overreliance on metabolic pathways 
involving glucose.  Colon cancer and breast cancer cells exhibit higher levels of glucose 
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consumption, PPP activity, and superoxides compared to normal counterparts, and cancer 
cells can compensate for increased ROS in part by increasing glucose consumption. 
However, when deprived of important nutrients, overwhelming levels of ROS can 
contribute to cell death (41). 
NADPH has also been found to be important for detoxification of ROS (42, 43). 
Keap1-knockout MEFs have higher levels of NADPH, which is required for regeneration 
of reduced forms of glutathione and is a cofactor for the antioxidant protein, NQO1.  
Keap1-knockout MEFs also increase glucose uptake by two-fold compared to wild-type 
MEFs and are less able to cope with glucose withdrawal (43). It has been concluded that 
these cells with reduced Keap1/ activated Nrf2 are less capable of detoxifying ROS when 
glucose is depleted due to decreased NADPH levels, which abrogates induction of some 
antioxidant genes when this important co-factor is unavailable (43). Nrf2 is very 
important for the overall oxidative state of a cell.  
2.6 Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) signaling 
 
Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) is a transcription factor that 
regulates expression of cytoprotective and antioxidant genes during oxidative stress. 
Under normal conditions, Keap1 (kelch-like-ECH-associated protein 1) binds with Nrf2 
in the cytoplasm leading to Nrf2’s ubiquitination and ultimately proteasomal degradation. 
Oxidative stress modifies Keap1, causing the release of Nrf2 which can then translocate 
to the nucleus, bind to the ARE (antioxidant response element) and transcribe cyto-
protective genes. Nrf2-regulated cyto-protective genes include NQO1 (NADPH quinone 
oxidoreductase 1) and GCLM (glutamate cysteine ligase) (44, 45). Nrf2 contributes to 
cell survival through several mechanisms, including upregulation of the antiapoptotic 
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protein Bcl2. Niture, et al. found that over-expression of Nrf2 causes an increase in Bcl2, 
therefore preventing death and potentially creating resistance to therapies. Knockdown of 
Nrf2, by contrast, was found to cause decreases in Bcl2 and NQO1, and loss of Bcl2 in 
turn causes cell death and DNA fragmentation, demonstrating the importance of Nrf2 in 
cell survival (44). 
Other proteins have also been implicated in interacting with the Nrf2-Keap1 
pathway. For example, p62, a protein important for bringing cargo to autophagosomes, 
can directly bind with Keap1 preventing it from binding to Nrf2, and thus causing its 
release. Especially in dysfunctional autophagy, p62 can form protein aggregates that can 
bind to Keap1 (46), increasing oxidative stress and leading to cytotoxicity (18). As 
discussed above, p62 is also involved in a paradoxical effect of autophagy where p62 
aggregates may bind to and activate TRAF6, causing NFkB activation and lowering pro-
apoptotic intracellular ROS, On the other hand p62 aggregates may bind caspase 8 and 









Figure 2.2 Nrf2 Pathway, adapted from “Oncogenic functions of the transcription factor 
Nrf2” (48) 
P21 is another protein, important in cell cycle arrest, DNA repair, and apoptosis, 
that is upregulated in response to oxidative damage. Chen, et al. found that p21 protects 
cells through upregulation of the Nrf2 pathway by competing with Keap1 for binding of 
Nrf2. By overexpressing p21 and finding that it had no effect on survival in Nrf2-null 
mouse embryo fibroblasts, these investigators verified that p21 needs Nrf2 for its survival 
role (49) and found that p21 directly interacts with Nrf2. Nrf2 interacts with multiple 
other proteins and pathways in order to carry out its antioxidant function in the cell.  
2.7 Nrf2 role in physiology  
Nrf2 signaling is vital to managing the over-accumulation of reactive oxygen 
species. Type II lung cells deficient in Nrf2 have decreased proliferation and are more 
sensitive to oxidant induced cell death. These  Nrf2-/- cells also had greater amounts of 
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intracellular reactive oxygen species (ROS) and low levels of the antioxidant, glutathione 
(GSH), and the antioxidant protein, glutamate-cysteine ligase modifier (GCLM) 
compared to wildtype cells. Supplementing with GSH restored proliferation to the Nrf2- 
null cells, however, treatment with the antioxidant NAC did not restore proliferation to 
the same level even though lower levels of ROS were measured with NAC treatment. 
The authors concluded that specifically a deficiency in Nrf2-GSH signaling impairs the 
type II cell growth (50). Nrf2 appears to be very important for the survival of cells by 
preventing ROS, and clearing the cells of ROS under oxidative stress. 
2.8 Nrf2 activation in autophagy and cancer 
A common denominator that involves autophagy, cancer and the Nrf2 pathway is 
reactive oxygen species (ROS). ROS, which are produced by mitochondria during 
oxidative phosphorylation, have been shown to regulate induction of autophagy; 
specifically, H202 oxidizes ATG4, resulting in increased formation of LC3II (36). ROS 
can also indirectly activate AMPK and downstream mTOR signaling (36). Cancers with 
activating RAS mutations have increased oxidative stress and need autophagy to tolerate 
this increased stress through preventing the accumulation of ROS that may damage 
proteins or DNA (36). 
Several studies have shown that when autophagy is blocked through either 
chemical or genetic means, ROS increase. Wang, et.al. studied the effect of melamine, a 
potential carcinogen, on cell death and found it causes an increase in reactive oxygen 
species production as well as an increase in autophagy. By inducing autophagy using 
rapamycin, there was increased cell survival and decreased ROS production while 
conversely blocking autophagy had the opposite effect. The authors concluded that 
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autophagy protects PC12 cells from melamine induced death in part by clearing excess 
ROS (35). Excess ROS were also measured in ATG7-/-  breast cancer cells, in a study by 
Gonzalez, et al. ATG7 knockout cells treated with MitoQ, a drug that targets the 
mitochondria, succumb to apoptosis whereas ATG7 wildtype cells underwent autophagy 
and survived, showing cells undergoing an oxidative stressor benefit from functional 
autophagy. Autophagy is beneficial when the cell’s main mechanism of antioxidant 
production, the Nrf2 pathway, is not sufficient enough to combat the amount of ROS. 
Decreased levels of ROS and lower levels of autophagy were found in Keap1 knockout 
cells due to the fact that Nrf2 was activated to a high enough level to rid the cell of extra 
ROS without needing the additional mechanism of autophagy (37). Therefore autophagy 
is extremely important in a setting where the Nrf2 pathway is not functional in order to 
maintain a cell’s survival. 
2.9 Hypoxia 
 
The tumor microenvironment not only consists of low nutrients but low levels of 
oxygen too as a result of poor vasculature. Cancer cells respond to the stress of hypoxia 
through the transcription factor HIF1 which increases glycolysis by upregulating glucose 
import proteins such as GLUT1 and decreases mitochondrial function by downregulating 
oxidative phosphorylation. Thus HIF1 helps reduce the cell’s demand for oxygen while 
providing energy for the cell. (51)  
It’s interesting to note that low glucose conditions may affect ATP levels and 
therefore HIF1α expression. Pancreatic and prostate cancer lines exposed to low glucose 
suppress the increase in HIF1α levels during hypoxia. Both proteasome degradation of 
HIF1α and decreased transcription were ruled out as mechanisms. It was found that 
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glucose deprivation decreased protein synthesis which may have occurred because of 
decreased ATP in the cell which is needed for translation (52). Zhou also found that as 
HIF1α declined so did the ATP levels (53). Another study showed HIF1α levels are 
decreased in perinecrotic regions of tumors despite being an area that is the most 
hypoxic, most likely because of nutrient deprivation (54).  
Presumably where hypoxia occurs, autophagy is likely to present too. Frezza et. al 
studied the metabolic profile of hypoxic cells and found that it had a catabolic signature. 
Autophagy was confirmed to be upregulated in these hypoxic cells and when autophagy 
was inhibited by bafilomycin A, ATP levels were depleted and significant cell death 
occurred. (55) Hypoxia is a stressor found in tumors that is important to study for its 
implication in cancer cell survival.  
 
2.10 ER+ and HER2+ Breast Cancer 
 
Breast cancer can be divided into 3 main categories based on receptor status: 
ER/PR positive, HER2 positive, and triple negative. Therapies such as Tamoxifen and 
Herceptin target these receptors. Approximately 50% of breast tumors rely on estrogen 
receptors (56). Tamoxifen prevents binding of the hormone estrogen to the estrogen 
receptor and prevents signaling therefore preventing growth (57, 58). HER2 is amplified 
in about 10% of breast cancers; this overexpression of HER2 promotes cell proliferation 
(56). Herceptin is a monoclonal antibody that binds to the HER2 receptor preventing 
HER2 signaling and therefore growth. These therapies work very well yet do not 
completely eradicate the cancer. Resistance can occur within a year even after an initial 
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response to treatment (59-61). The mechanism of resistance is important to study for 
future advancements in drug discovery and therapy.  
Autophagy may be this mechanism, promoting cancer cell survival and 
preventing the therapies from effectively killing all cells.  In studies performed by Qadir 
MA et al. cells were subjected to several conditions including tamoxifen, and siRNA for 
autophagy plus tamoxifen treatment. Cells treated with siRNA to the autophagy 
components ATG7, Beclin1, and ATG5 showed more sensitivity to tamoxifen. (59). 
Qadir MA also conducted studies in which cells were incubated with tamoxifen for 72 
hours and visualized for LC3 by fluorescent microscopy. During Tamoxifen treatment, 
the GFP-LC3 became punctate indicating autophagosomes were forming in response to 
tamoxifen (59). As a result, the efficacy of targeted drug therapies may be increased by 
targeting autophagy.  
While Qadir MA showed that autophagy may be a factor in drug efficacy, Nahta 
R et al. found that when SKBR3 parental cells are compared to trastuzumab resistant 
pools of cells, they had equal amounts of HER2 protein. However when the pools were 
maintained in trastuzumab there was a downregulation of HER2 in these resistant cells 
compared to the parental cells where HER2 did not change (62). Vazquez-Martin et al 
also studied the trastuzumab refractory cells and found that autophagy was upregulated in 
these resistant pool compared to naïve cells (63). With this information, I came to the 
hypothesis that metabolic stress-induced autophagy downregulates ER and HER2 in 
breast cancer cells, resulting in an attenuated response to targeted drug therapies. This 
hypothesis was explored and while seemingly not correct, produced some interesting data 
that will be discussed in chapter 6.
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In human tumors, cancer cells often encounter ischemia and require activation of 
various cell survival mechanisms to withstand this metabolic stress.  Autophagy is one 
important potential mechanism for providing energy and essential nutrients during 
metabolic stress, but the role of autophagy during nutrient deprivation – and specifically 
glucose deprivation - has been an area of dispute (64).  In multiple experiments, 
knockdown of genes essential for autophagy in cells deprived of serum or amino acids 
was found to lead to cell death by apoptosis (65, 66), and  autophagy has also been shown  
to protect cancer cells from the glycolytic inhibitor 2-deoxyglucose (2-DG) (67-69).  
While incubating cells with 2-deoxyglucose might be expected to mimic the situation of 
glucose deprivation, experiments testing glucose free medium in a variety of cultured cell 
lines, did not find a protective role for autophagy in the setting of glucose deprivation 
(70).   
Cellular responses to glucose deprivation are probably variable among cell types 
with different molecular backgrounds, and in addition to the process of autophagy, other 
cellular adaptations likely have complementary or parallel role for cell survival during 
metabolic stress.  Other sections of this thesis will describe my work on how induction of 
Nrf2 activity is also critical for survival of cells during glucose deprivation, which was an 
unexpected finding because previous studies have found that autophagy leads to reduced 
levels of p62 (33, 46, 71), which in turn would be expected to allow Keap1 to bind the 
Nrf2 transcription factor and lead to increased degradation of Nrf2 protein.      
 
 22 
3.2 MATERIALS AND METHODS 
 
3.2.1 Cell Culture  
 
Human cancer cell line MCF7 was cultured in DMEM media (Gibco) supplemented with 
10% fetal bovine serum (FBS) (Gibco). T47D was cultured in RPMI (Gibco) 
supplemented with 10% FBS. Experiments requiring glucose deprivation used RPMI 
glucose free media (Gibco) 0.1%FBS. DMEM glucose free media was made from DME 
base (Sigma Aldrich) dissolved in ultrapure water and supplemented with sodium 




Primary antibodies for ATG7, Beclin1, cleaved PARP (Asp214), and PARP were 
purchased from Cell Signaling Technology. LC3B was purchased from Novus 
Biologicals. p62 antibody was purchased from Santa Cruz. Anti-Actin antibody was 
purchased from Sigma-Aldrich.  Anti-rabbit and anti-mouse secondary antibodies were 
purchased from Cell Signaling Technology. Chloroquine, a pharmacological inhibitor of 
autophagy, was dissolved in water to make a 25mM stock concentration. Puromycin was 
purchased from Sigma and dissolved in ultrapure water to make a 10mg/ml stock 
solution.  Alexa Fluor 488 Donkey anti-rabbit IGg and Alexa Fluor 594 Goat anti-mouse 
IGg were purchased from Invitrogen. Prolong Gold antifade reageant with DAPI by 




3.2.3 Clonogenic Assays 
 
MCF7 and T47D were plated at appropriate density ranging from 500 to 3000 cells per 
well. After 24 hours incubation, cells were treated with complete or glucose free medium 
for variable amounts of time with the most common being 72 hours. In other 
experiments, cells were treated with complete or glucose free media long with variable 
concentrations of chloroquine according to the experiment.  After treatment with the 
different mediums and drugs, cells were replenished with complete media without drug 
and allowed to grow for an average time of 10 days before being fixed with 100% 




MCF7 cells were plated at a density of 1500 per chamber slide well. After incubation 
with complete or glucose free media and for 48 hours, slides were washed with PBS and 
fixed for 10 minutes in Zn Formalin. Cells were permeablized with .1% Triton-PBS for 
10 minutes and then blocked with 5%BSA in PBS for 1 hour before adding primary 
antibody (1:200 dilution) and incubating overnight at 4ºC. The slides were then washed 3 
times for 10 minutes each and then incubated with secondary antibody (1:200 dilution) ( 
Alexa Fluor 488 Donkey anti-rabbit IGg and Alexa Fluor 594 Goat anti-mouse IGg) for 1 
hour in the dark. Slides were washed again and DAPI was added to the slide and covered 
with a coverslip. Images were taken using Nikon eclipse 50i and the program NIS-





After experimental treatment, cells were harvested in TNE lysis buffer plus protease 
inhibitor and protein concentration was determined using Pierce BCA assay (Thermo 
Fisher Scientific). Equal amounts of protein were loaded for each sample, separated by 
SDS-PAGE on a 10% or 10-20% gel Tris-HCl gel (Bio-Rad) and incubated overnight 
with primary antibody in 4ºC. Most antibodies were incubated at a 1:1000 concentration. 
Exceptions include actin (1:20,000), and sigma antibodies (1:500). After washing and a 
1.5 hour incubation with anti-rabbit or anti-mouse secondary antibody at room 
temperature, membranes were developed with SuperSignal West Femto Max Sensitivity 
Substrate ( Thermo Fisher Scientific). Some membranes were stripped with Stripping 
Buffer (Thermo Fisher Scientific) and re-probed with other primary antibodies.  
 
3.2.6 Flow Cytometry  
 
T47D and MCF7 cells were grown to sub-confluency in 100mm cell culture plates and 
grown in complete or glucose free media for 72 hours. At the designated time, cells were 
trypsinized with 0.25% Trypsin-EDTA, collected and then washed with PBS. Cells were 
resuspended in 0.3ml PBS and fixed with 5ml of a 1:1 methanol:acetone mixture. Fixed 
cells were centrifuged for 5 minutes at 2,000 RPM and buffer decanted. The cell pellet 
was suspended in 5ml of PBS, and then centrifuged for 5 minutes at 2,000 RPM. After 
aspirating PBS, 0.25ml of 5ug/ml RNase was added with a wait time of 15 minutes at 
37C. Next 0.25ml of 100ug/ml PI solution was added for an incubation time of overnight. 
Fixed cells were stained with Propidium Iodide (Sigma) for 1 hour. Propidium Iodide 
fluorescence of the samples was determined by FACS.  
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3.2.7 CRISPR/Cas-9 Transfection 
 
 
5ug of lentiCRISPRv2 plasmid (Plasmid #52961) was digested and dephosphorylated 
with BsmB1 for 30 minutes at 37ºC. The digested plasmid was purified using  QIAquick 
gel extraction kit and eluted in distilled water. Next, oligos for ATG7 and Beclin 1 were 
phosphorylated by T4 poly nucleotide kinase and annealed at 37ºC for 30 minutes, 
followed by 95ºC for 5 minutes and ramping down to 25ºC at 5C/minute. Digested 
lentivirus and annealed oligos were followed by a ligation reaction and incubated at room 
temperature for 10 minutes. The ligated DNA were transformed into Stbl3 bacteria and 
positive colonies were selected on ampicillin contained LB agar media and cultured in 
ampicillin contained LB media. Supernatant was harvested and DNA was then purified 
using Invitrogen PureLink HiPure Plasmid Filter Midiprep  Kit. Correct insertion was 
verified using sequencing. lentiCRISPR with inserted sequences were co-transfected into 
HEK293T cells with packinging plasmids pVSVg and psPAX2. MCF7 cells were then 
transfected twice, allowed to grow for 3-4 days cells and selected for a week. Cells were 
diluted into a 96 well plate and single colonies were picked. Knockdown of ATG7 and 
Beclin1 were verified by immunoblot and Cas9 antibody. Knockdown cells were 
maintained in DMEM with 1ug/ml of puromycin. lentiCRISPR v2 was a gift from Feng 













ATG7 NM_006395.2 Forward 1:    
5’CACCGAATCAAGTATGATGAGAACA3’ 
Reverse 1:      
5’AAACTGTTCTCATCATACTTGATTC3’ 
Forward 2:     
5’AAACTGTTCTCATCATACTTGATTC3’ 
Reverse 2:     
5’AAACGGACGACTCACAGTGCACTGC3’ 
Beclin1 NM_003766.3 Forward 1:    
5’AAACGGACGACTCACAGTGCACTGC3’ 
Reverse 1:    
5’AAACGCATGGTGCTGTTGTTGGACC3’ 
Forward 2:   
5’CACCGGCCAACAGCTTCACTCTGAT3’ 
Reverse 2:    
5’AAACATCAGAGTGAAGCTGTTGGCC3’ 
 























3.3.1 Glucose deprivation results in the induction of autophagy in cultured 
breast cancer cells  
 
Although autophagy is generally believed to have an essential role in supporting 
cell survival during nutrient deprivation, conflicting data has been presented regarding 
the role of autophagy in the setting of glucose deprivation. Accordingly, we cultured 
MCF7 and T47D breast cancer cells in glucose-free medium for variable periods, and to 
measure effects of the nutrient deprivation on cell survival, we then replenished nutrients 
with full media for seven days and measured clonal growth of surviving cells.  
Accordingly, we cultured MCF7 and T47D breast cancer cells in glucose-free medium to 
test for cell viability over several days. As seen in Figure 3.1A cell death occurs 
noticeably at 72 hours. To further assess cell viability at 3 days of glucose deprivation, 
we cultured MCF7 and T47D, in glucose-free media for 3 days and replenished nutrients 
with complete media for 10 days to measure clonal growth of surviving cells. Both cell 
lines generally tolerate up to approximately three days of glucose-free media (Fig 3.1B, 
and Fig 3.1C).  
To determine whether autophagy is induced by this glucose deprivation, we 
measured conversion of the microtubule-associated protein light chain 3 protein (LC3) 
from the LC3I form to the LC3II form, which is considered to be characteristic of 
autophagy.  As seen in Figure 3.2, the ratio of LC3II:LC3I increases with glucose 
deprivation in both T47D and MCF7, particularly after the addition of chloroquine, which 
raises lysosomal pH and prevents fusion and degradation of lysosomal proteins, thus 
enhancing detection of increases in LC3II.  Although actin loading for 72 hours of 
glucose deprivation is unequal, presumably the LC3II levels in the chloroquine treated 
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lane would be further increased, still supporting an increase in autophagy. Glucose 
deprivation for two days also results in the appearance of a punctate staining pattern of 
LC3II, which indicates the presence of autophagosomes typical for autophagy (Fig 3.3). 
3.3.2Pharmacologically blocking autophagy decreases survival of breast 
cancer cells during glucose deprivation  
 
We then tested the significance of autophagy in survival of breast cancer cells 
during glucose deprivation.  First, we tested how chloroquine treatment, which blocks 
completion of autophagy, affects survival.  As seen in Figure 3.4A , addition of 
chloroquine at levels that alone do not affect cell growth do cause loss of cell viability, 
when T47D cells are grown in glucose-free conditions for three days.  Inhibition of 
autophagy during glucose deprivation using chloroquine similarly results in loss of cell 
viability in MCF7 cells (Fig 3.4B).  As reported in other experimental systems, cell death 
in this setting is associated with changes typical for apoptosis, including cell 
fragmentation (Fig 3.4A) and increases in cleaved poly-ADP-ribose polymerase (Fig 
3.5). 
3.3.3Knockout of genes required for autophagy also decreases survival of 
breast cancer cells during glucose deprivation  
 
To more specifically measure the role of autophagy in cell survival, we then used 
a CRISPR-Cas9 approach to knock out two genes that are critical for autophagy: ATG7 
and beclin-1.  Data shown in Figure 3.6A demonstrates that this strategy results in the 
complete knockout of expression of these targeted genes in MCF7 cultures, and Figure 
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3.6B shows that knockout of expression of these genes results in greatly reduced survival 
after glucose deprivation.  Survival of cells transfected with a control vector are 
unaffected and retain the ability to survive three days of glucose deprivation, and 
knockout of either ATG7 or beclin-1 does not affect survival of cells cultured with full 
media.  Thus, glucose deprivation leads to induction of autophagy in breast cancer cells, 
and this autophagy contributes to survival of cells for several days of glucose deprivation. 
3.3.4Autophagy is responsible for reduced levels of p62 during glucose 
deprivation 
 
Previous studies demonstrated that autophagy can lead to degradation of 
endogenous p62 or ectopic expression of p62, and in accordance with these previously 
reported findings, we also observed decreased levels of p62 in cultures of MCF7 cells at 
48 hours or 72 hours of glucose deprivation, when compared to control cultures with full 
glucose media (Fig 3.7A and Fig 3.7B).  Decreases in levels of p62 were evidently 
dependent on autophagy, since p62 levels did not decrease in cells that had ATG7 or 













In our studies using breast cancer cells, glucose deprivation resulted in autophagy, 
which in turn allowed survival of the cells for approximately three days in these 
starvation conditions. Autophagy was demonstrated in our experiment by measuring the 
LC3II : LC3I ratio and visualizing the induction of punctate LC3 foci in cells during 
glucose deprivation.  The importance of autophagy in cell survival was demonstrated by 
reduced clonogenicity when autophagy was obstructed by pharmacological agents such 
as chloroquine or by knockout of proteins that are key in the autophagic process.  
Autophagy has been shown to be critical for cell survival in many settings of 
cellular stress (73) including ER stress, hypoxia, redox stress, mitochondrial damage and 
metabolic stress. However, the role of autophagy in cell survival during nutrient 
deprivation- and specifically glucose deprivation- has been an area of dispute (64). 
Knockdown of essential autophagic genes in cells deprived of serum or amino acids lead 
to cell death by apoptosis and autophagy has been shown to protect cancer cells from 2-
deoxyglucose, a glycolytic inhibitor, which could represent a metabolic setting similar to 
glucose deprivation. In experiments that directly tested glucose deprivation, however, 
autophagy reportedly did not protect a variety of cell lines culture in this setting.  
Our experiments provide a direct demonstration that in MCF7 and T47D breast 
cancer cells, autophagy is induced by glucose deprivation and is critical for survival of 
these cells in this setting for up to three days. While differences between our results and 
those previously reported for glucose deprivation cannot be easily explained, we note that 
almost certainly, cellular responses to glucose deprivation will vary among different cell 
types with different molecular backgrounds. This may be especially true in cancer cells. 
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Indeed, some cancer cells are highly dependent on glutamine as their energy source and 
for these cells, glucose deprivation might be of little consequence. Moreover, as I will 
show later in this thesis, other cellular protective mechanisms, including Nrf2, might be 
critical for survival in the setting of glucose deprivation.  
While autophagy is important for providing critical nutrients and energy during 
metabolic stress, one of its key players, p62, an LC3-interacting, ubiquitin associated 
protein, is involved with Nrf2 signaling.  When autophagy is dysfunctional, p62 has been 
shown to interact with Keap1, sequestering it, which in turn leads to induction of 
antioxidant Nrf2 signaling. Our studies have shown that, as expected, autophagy induced 
by glucose deprivation reduces levels of p62. Presumably in this setting, levels of Keap1 
would increase, thus enabling the ubiquitination and degradation of Nrf2. In the next 
chapter we’ll explore whether this interaction between Keap1 and p62 affects Nrf2 
signaling in glucose deprivation.  
The induction of autophagy and the protective effects of this process during 
glucose deprivation could be important for survival of cancer cells in situation of 
metabolic stress, such as ischemia. In fact, substantial date points to autophagy 
contributing to cancer development in a variety of experimental settings. Particularly in 
cancers with RAS mutations, experimental data indicates that autophagy is critical for 
growth and survival of cancer cells. In most cancerous tumors, the disordered 
microenvironment is associated with metabolic stress due to variable hypoxia and 
nutrient insufficiency, and in this setting autophagy appears to have an essential role in 
recycling intracellular macromolecules and organelles to transiently provide essential 
















Figure 3.1 Breast cancer cells survive nutrient deprivation. (A) MCF7 cells were 
cultured in complete or glucose free media for 24, 48, 72, or 144 hours and then fixed 
with MeOH and stained with crystal violet. Cells are tolerant of glucose deprivation for 
several days.   (B) After attachment, T47D and MCF7 cells were cultured in either 
complete media (top row) for a total of 10 days, or glucose free media (bottom row) for 
72 hours followed by complete media for an additional 10 days. Cells were fixed and 
stained with crystal violet. (C) MCF7 cells were cultured in complete or glucose free 
media for 1, 3 or 5 days after which they were replenished with complete media for 10 
days. Bottom two wells were treated with 7uM chloroquine. When colonies were visible 




Figure 3.2 Breast cancer cells induce autophagy during glucose deprivation. T47D 
and MCF7 cells were grown in complete media or glucose free media for 48 or 72 hours 
and assayed for LC3 by immunoblot. Cells were treated with 25uM chloroquine to assess 
autophagic flux.  Increased levels of the LC3II form of the protein, characteristic of 
autophagy, is seen in glucose deprivation conditions, and the addition of chloroquine, 




Figure 3.3 Punctate autophagosomes are increased during glucose deprivation. 
Breast cancer cell lines, T47D and MCF7, were grown in either complete media or 
glucose free media for one day, and LC3II was visualized using immunofluorescence.  In 
contrast to the diffuse, green LC3II staining of breast cancer cells grown in complete 
media, punctate staining is seen when cells are cultured in glucose deprivation, typical of 









Figure 3.4 Autophagy is essential for survival during nutrient deprivation. (A) T47D 
cells were analyzed for cell cycle by flow cytometry. All treatments were carried out for 
72 hours, then cells were fixed. Chloroquine (25uM), an autophagic inhibitor, had little 
effect on cells grown in complete media. Cells grown in glucose free media have an 
increased subG1 population. Cells grown in glucose free media and treated with 
chloroquine for 72 hours have an even larger increase in subG1 population. The inset on 
each flow diagram consists of T47D cells plated in 6 well plates and subjected to the 
same conditions shown by FACs. After 72 hours, all cells were grown in complete media 
to allow formation of colonies to be stained by crystal violet. (B) MCF7 cells were 
treated with complete or glucose free media with or without chloroquine (7uM) for 72 
hours, replenished and stained with crystal violet.  
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Figure 3.5 MCF7 cells undergo apoptosis when autophagy is blocked during glucose 
deprivation.  MCF7 cells were grown in complete media or glucose free media for 48 or 
72 hours with or without 25uM chloroquine and assayed for cleaved PARP by 









Figure 3.6 Genetic knockout of  autophagic proteins decreases survival (A) MCF7 
cells were transfected with CRISPR constructs ATG7, Beclin1, and a control vector V2. 
Knockout of ATG7 and Beclin1 were achieved. (B) MCF7 CRISPR cell lines were 
grown in complete or glucose free media for 72 hours followed by complete media for 7 




Figure 3.7 p62 is decreased during glucose deprivation. (A)  MCF7 cells were grown 
in complete media or glucose free media for 48 or 72 hours with or without 25uM 
chloroquine and assayed for p62 by immunoblot. (B) MCF7 cells were grown in 
complete media or glucose free media for 48 or 72 hours and assayed for p62 by 
immunoblot. (C) Cells were grown in complete or glucose free media with or without 
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The previous section of this thesis describes our findings that, a) cultured breast 
cancer cells are capable of surviving glucose deprivation for several days, b) autophagy is 
induced by glucose deprivation results in these breast cancer cells, and c) autophagy is 
critical for cell survival in this setting.  Since other cellular adaptations likely have 
complementary or parallel role for cell survival during metabolic stress, we investigated 
what protective molecular pathways might be triggered by autophagy in the setting of 
glucose deprivation.  In particular, my studies focused on Nrf2 signaling and its tie to 
autophagy through p62, an LC3-interacting, ubiquitin-associated protein.  In various 
disease settings, p62 accumulates in cytosolic protein aggregates and in cellular inclusion 
bodies together with polyubiquitinated proteins. Autolysosomes containing p62- and 
LC3-positive bodies are degraded by autophagy (74), resulting in decreased levels of p62.  
Consequently, in previous experiments and as presented in Chapter 3, autophagy 
was found to result in reduced levels of p62, (33, 46, 71). Interestingly, p62 has been 
shown to sequester Keap-1 protein (74, 75), however if p62 levels are down, it would be 
expected to allow Keap1 to bind the Nrf2 transcription factor and lead to increased 
degradation of Nrf2 protein.   
This chapter will describe my unexpected finding that Nrf2 protein levels and 
Nrf2 activity are actually increased in the setting of glucose deprivation, which is an 
unforeseen finding in light of previously reported findings that decreases in p62 lead to 
decreases in Nrf2.  I will describe how this increase in Nrf2 is independent of autophagy, 
and also independent of reactive oxygen species, which do increase in glucose-deprived 
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cells.  In addition, I’ll present my findings from testing the role of Nrf2 in cell survival 



























4.2 MATERIALS AND METHODS 
 
4.2.1 Cell Culture 
 
Human cancer cell line MCF7 was cultured in DMEM media (Gibco) supplemented with 
10% fetal bovine serum (FBS) (Gibco). T47D was cultured in RPMI (Gibco) 
supplemented with 10% FBS. Experiments requiring glucose deprivation used RPMI 
glucose free media (Gibco) 0.1%FBS. DMEM glucose free media was made from DME 
base (Sigma Aldrich) dissolved in ultrapure water and supplemented with sodium 
bicarbonate, sodium pyruvate, L-glutamine and 0.1%FBS. MCF7shRNA cells were 




Primary antibodies for NQO1, cleaved PARP (Asp214), and PARP were purchased from 
Cell Signaling Technology. GCLM was purchased from Novus Biologicals. p62, and 
Nrf2 antibodies were purchased from Santa Cruz. Anti-Actin antibody was purchased 
from Sigma-Aldrich.  Anti-rabbit and anti-mouse secondary antibodies were purchased 
from Cell Signaling Technology. Chloroquine, a pharmacological inhibitor of autophagy, 
was dissolved in water to make a 25mM stock concentration. Glutathione (GSH) (Sigma) 
was dissolved in water to make a 50mM stock concentration. N-acteyl-cysteine (NAC) 
(Sigma) was prepared in water to make a 500mM stock concentration. Puromycin was 
purchased from Sigma and dissolved in ultrapure water to make a 1mg/ml stock solution. 
ML-385, Nrf2 inhibitor, was provided by Anju Singh in the Biswal Lab and dissolved in 
DMSO for a stock concentration of 10mM. Alexa Fluor 488 Donkey anti-rabbit IGg and 
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Alexa Fluor 594 Goat anti-mouse IGg were purchased from Invitrogen. Prolong Gold 
antifade reageant with DAPI by Molecular Probes Life Technologies was used to stain 
the nucleus in immunofluorescence experiments. CM-H2DCFDA was purchased from 




After experimental treatment, cells were harvested in TNE lysis buffer plus protease 
inhibitor and protein concentration was determined using Pierce BCA assay (Thermo 
Fisher Scientific). Equal amounts of protein were loaded for each sample, separated by 
SDS-PAGE on a 10% or 10-20% gel Tris-HCl gel (Bio-Rad) and incubated overnight 
with primary antibody at 4ºC. Most antibodies were incubated at a 1:1000 concentration. 
Exceptions include actin (1:20,000), and sigma antibodies (1:500). After washing and a 
1.5 hour incubation with anti-rabbit or anti-mouse secondary antibody at room 
temperature, membranes were developed with SuperSignal West Femto Max Sensitivity 
Substrate ( Thermo Fisher Scientific). Some membranes were stripped with Stripping 




MCF7 shRNA cell lines were plated at a density of 1500 per chamber slide well. After 
incubation with complete or glucose free media for 48 hours, slides were washed with 
PBS and fixed for 10 minutes in Zn Formalin. Cells were permeablized with .1% Triton-
PBS for 10 minutes and then blocked with 5%BSA in PBS for 1 hour before adding 
primary antibody and incubating overnight at 4ºC. The slides were then washed 3 times 
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for 10 minutes each and then incubated with secondary antibody (Alexa Fluor 488 
Donkey anti-rabbit IGg and Alexa Fluor 594 Goat anti-mouse IGg) for 1 hour in the dark. 
Slides were washed again and DAPI was added to the slide and covered with a coverslip. 
Images were taken using Nikon eclipse 50i and the program NIS-Elements BR 3.2.  
 
4.2.5 shRNA Transfection 
 
MCF7 cells were transfected with Keap1 shRNA, Nrf2 shRNA and control luciferase 
shRNA. Lentivirus was supplied by Anju Singh. Cells were plated at 30-40% confluence. 
8ug/ml of polybrene was added to viral supernatant and incubated for 10 minutes at room 
temperature. This mixture was mixed with fresh media and added to the cells and 
incubated overnight. The next day the culture medium with polybrene and lentivirus was 
replaced with fresh media. Cells were selected with 750ng/ml of puromycin.  
 
4.2.6 q-PCR/quantitative PCR 
 
After transfection, MCF7 Nrf2shRNA, MCF7 Keap1shRNA, and MCF7 LucshRNA cells 
were analyzed for mRNA levels of the transcripts for Nrf2, Keap1, NQO1, and Gclm to 
ensure transfection was efficient. 1ug of RNA was used for cDNA synthesis using ABI 











Multiscribe reverse transcriptase 1ul 
Water 4.2ul 
 Total Volume= 
20ul 
Table 4.2.1 RT-PCR/cDNA synthesis mixture 
 
25ºC 10 minutes 
37ºC 2 hours 
85ºC 10 minutes 
Table 4.2.2 RT-PCR cDNA synthesis cycling conditions 
 
 
The cDNA was then diluted 5 times in water, and used for real time PCR using Taqman 
primer/probe mix and ABI gene expression mastermix.  
 
2X mastermix 10ul 
20X Taqman primer/probe mix 1ul 
cDNA 5ul 
Water 4ul 
Table 4.2.3 qPCR reaction mixture 
 
1 cycle 95ºC for 20 seconds 
40 cycles  95ºC for 1 second, 
60ºC for 20 seconds 











Table 4.2.5 Taqman primer probe sequences for qPCR 
 
Statistical significance was determined by upaired t-test in GraphPad Prism4 from 
GraphPad Software, Inc., La Jolla, CA. 
 
4.2.6 Clonogenic Assays 
 
MCF7 and T47D were plated at appropriate density ranging from 500 to 3000 cells per 
well. After 24 hours incubation, cells were treated with complete or glucose free medium 
for variable amounts of time with the most common being 72 hours. In other 
experiments, cells were treated with complete or glucose free media with 2uM ML-385, 
2mM NAC, or 2.5mM GSH according to the experiment.  After treatment with the 
different mediums and drugs, cells were replenished with complete media without drug 
and allowed to grow for an average time of 10 days before being fixed with 100% 
methanol and stained with 0.5% crystal violet (Sigma). 
 
4.2.7 ROS Measurements 
 
MCF7 were plated at a density of 7000 -10,000 cells per well in a 96 well plate. After 24 
hours incubation, media was changed to complete DMEM or DMEM glucose free media. 
At 12 and 24 hour time points, cells were aspirated and washed with PBS. CM-
H2DCFDA, dissolved in ethanol to a final concentration of 20uM in PBS, was added to 
the wells and incubated for 30 min. Cells were then aspirated, and 10%FBS in PBS was 
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added and incubated for 30 min. Wells were aspirated and fluorescence was measured 
using Filter Max F5 (Multi-mode Microplate Reader, Molecular Devices) and Soft Max 
Pro 6.3 software at an excitation of 495 and emission of 520. Statistical significance was 























4.3.1The Nrf2 transcription factor is unexpectedly induced in breast cancer 
cells during nutrient deprivation 
 
As noted above, in the presence of p62, Nrf2 levels increase, but in the absence of 
p62, Nrf2 levels would be expected to decrease.  Interestingly, Nrf2 activity is often 
activated in human cancers, leading us to question how autophagy might affect this 
pathway in cancer.  We first tested whether Nrf2 is decreased by nutrient deprivation in 
breast cancer cells by measuring levels of Nrf2.  As shown in Figure 4.1A, levels of Nrf2 
surprisingly increase in MCF7 cells when cultured in the absence of glucose. Induction of 
Nrf2 was also confirmed using immunofluorescence to measure the levels of the Nrf2-
regulated transcript, NADPH dehydrogenase quinone1 (NQO1), a major antioxidant 
protein. As seen in Figure 4.1B, cells cultured with glucose deprivation conditions have 
increased NQO1 expression compared to control cultures.   
4.3.2Induction of the Nrf2 transcription factor is critical for survival of 
breast cancer cells during nutrient deprivation-induced autophagy 
 
Although activation of Nrf2 is glucose deprivation was unexpected, based on 
previously published experiments, we noted that Nrf2 activity is often activated in human 
cancers and is an important protective of cells in response to a variety of stresses.  The 
role of Nrf2 thus led me to question how increased Nrf2 might affect survival in the 
setting of glucose deprivation.   
To test whether this unexpected increase in Nrf2 protein and activity has a role in 
survival of glucose-deprived breast cancer cells, we transfected shRNA designed to 
knock-down levels of Keap1 or Nrf2 transcripts. qPCR was performed to determine that 
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the transfection was successful. As shown in Figure 4.2A both Nrf2 and Keap1 were 
knocked down and increases of Nrf2-regulated mRNA transcripts was increased in the 
Keap1 knockdown cells as expected.  Furthermore, the shRNA targeting Keap1 increases 
levels of Nrf2-regulated antioxidant proteins NQO1 and Gclm , whereas levels of these 
proteins show minimal to no decrease by shRNA targeting Nrf2 when compared to 
luciferase control (Fig 4.2B) .  
Examining survival of cells using clonal growth assays either in full media or 
glucose deprivation, I found that cells depleted of Keap1 show only a modestly improved 
survival compared to control cultures (Fig 4.3A and Fig 4.3B).  This result likely reflects 
our previous observation that Nrf2 levels are increased by glucose deprivation alone, 
even without knockdown of Keap1, and thus knockdown of Keap1 by shRNA likely has 
minimal additive effect.  More remarkably, however, cells depleted of Nrf2 have 
significantly impaired survival after glucose deprivation compared to cells that were 
transfected with a control luciferase shRNA, demonstrating that Nrf2 has a critical role in 
survival of these cells during glucose deprivation (Fig 4.3A and Fig 4.3B). The 
importance of Nrf2 was also investigated using the Nrf2 inhibitor ML-385. Treatment of 
both autophagy-competent and autophagy-deficient cells with 2uM ML-385 resulted in 
increased cell death in glucose free media but not complete media when compared to the 
untreated control plate (Fig 4.4).  Thus, our experiments find that the increased Nrf2 
expression and activity in the setting of glucose deprivation have a critical role in survival 
of breast cancer cells in this setting. 
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4.3.3Glucose deprivation results in increased levels of reactive oxygen 
species, and protective effects of Nrf2 are mediated by antioxidant activity 
 
As demonstrated above as well as in previously reported studies, Nrf2 activity 
regulates levels of the antioxidant protein, NADPH dehydrogenase quinone 1 (NQO1), 
resulting in protection from reactive oxygen species (ROS).  To explore how glucose 
deprivation and Nrf2 activity affect cellular levels of ROS, we used 2',7'-
dichlorodihydrofluorescein diacetate (DCFDA), a cell-permeable, chemically reduced 
form of fluorescein, as an indicator for ROS in cells. As shown in Figure 4.5A, cultures 
of cells with knockdown of Nrf2 showed time-dependent increases in ROS when cultured 
in glucose-free medium.  By contrast, cells with knockdown of Keap1 showed 
significantly less ROS when cultured in glucose-free medium.  These results show that 
cellular levels of ROS are increased during glucose deprivation, and that Nrf2 (especially 
when induced by knockdown of Keap1) is important for attenuating this oxidative stress. 
With these data pointing to Nrf2 activity playing a critical role for cell survival 
during nutrient deprivation-induced autophagy, we then tested whether the antioxidants, 
N-acetyl cysteine and glutathione, could also protect cell survival during autophagy.  
Indeed, these two antioxidants protect survival of Nrf2-depleted cells experiencing 
glucose deprivation (Fig 4.5B), suggesting that the role of increased Nrf2 during glucose 
deprivation involves coordinating an anti-oxidant response.  
4.3.4Induction of the Nrf2 transcription factor is independent of autophagy 
and oxidative stress 
 
As discussed above, these increases in Nrf2 levels were unexpected in light of the 
decreased levels of p62 that I observed in glucose-deprived cultures.  Therefore, I 
investigated whether increases in Nrf2 were dependent or independent of autophagy.  
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Using strategies to block autophagy that were described in the previous chapter, I found 
that Nrf2 levels increase in glucose-deprived cells, even when cultures are treated with 
chloroquine (Fig 4.6).  Furthermore, increases in Nrf2 occur in glucose-deprived cells 
with knock-out of ATG or Beclin.  Therefore, I conclude that increases in Nrf2 levels are 
not direct consequence of glucose deprivation- induced autophagy.   
Nrf2 has an important role in protecting cells from oxidative stress, and oxidative 
stress can actually induce increased Nrf2 activity by inactivating KEAP1 (76, 77).  To 
determine whether oxidative stress is important for the induction of Nrf2 in glucose 
deprivation, I tested whether N-acetyl cysteine affects the decreases in p62 and increases 
in Nrf2 levels during glucose deprivation. As shown in Figure 4.7, N-acetyl cysteine does 
not affect the decreases in p62 and increases in Nrf2 levels during glucose deprivation, 
suggesting that neither of these processes are initiated by high levels of reactive oxygen 














The previous chapter described how, using breast cancer cells, I found that 
glucose deprivation resulted in autophagy, which in turn allowed survival of the cells for 
approximately three days in starvation conditions. The importance of autophagy in cell 
survival in these starvation conditions was demonstrated by reduced clonogenicity when 
autophagy is blocked by pharmacological agents or by knockout of proteins important in 
autophagy. Autophagy initiated by glucose deprivation also leads to decreases in p62.  
In light of the previously described relationships between p62, Keap1 and Nrf2, my 
finding that levels and activity of the antioxidant protein, Nrf2, increase during glucose 
deprivation was surprising. These increases in Nrf2 protein levels are not dependent on 
autophagy, since Nrf2 increased in cells with knockout of ATG7. I also explored the 
possibility that oxidative stress is responsible for increasing levels of Nrf2 during glucose 
deprivation, and indeed, we did find increased levels of ROS in glucose deprived 
cultures. This increase in ROS was attenuated by an increase in the level of Nrf2 
signaling as evidenced by Keap1 knockdown cells. However, introduction of NAC into 
glucose-free conditions did not change the increase of Nrf2. Therefore, we conclude that 
the induction of Nrf2 does not rely on reactive oxygen species. Nrf2 can also be activated 
by various transcriptional, epigenetic, and post-translational mechanisms and the question 
of what mechanisms are responsible for activation of Nrf2 in glucose deprivation should 
be investigated in future studies. In addition, Nrf2 is obviously important for survival of 
breast cancer cells as demonstrated by the impaired survival of Nrf2 knockdown cells 
grown in glucose free media. This was confirmed by drug studies in which glucose 
deprived cells treated with an Nrf2 inhibitor showed decreased survival compared to 
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untreated glucose deprived controls. This has important implications for treatment of 


















































































Figure 4.1 Nrf2 is activated by nutrient deprivation.  (A) Increased expression of Nrf2 
is seen in MCF7 cells grown in glucose free media for 24, 48, and 72 hours. (B) 
Increased expression of NQO1, an Nrf2-regulated transcript, in MCF7 cells after 48 
hours of glucose deprivation.  Fluorescence immunohistochemistry was used to measure 
Nrf2 levels in MCF7 cultures grown in complete media or glucose-free media for 48 





















Figure 4.2 Knockdown of Keap1 and Nrf2 in MCF7 cells (A) After transfection of 
MCF7 cells with Nrf2 shRNA , Keap1 shRNA, or control (luciferase) shRNA, mRNA 
levels of Nrf2, Keap1, Gclm, and NQO1 were measured using q-PCR. Differences 
compared to control that are significant by t-test are designated by asterisks. (p=0.0039 
Nrf2 mRNA: LucshRNA vs. Nrf2shRNA, p=0.0323 Gclm mRNA: LucshRNA vs. 
Nrf2shRNA, p=0.005 Gclm mRNA: LucshRNA vs. Keap1shRNA, p=0.003 NQO1 
mRNA: LucshRNA vs. Keap1shRNA) (B) The effect of Nrf2 and Keap1 knockdown on 
Nrf2’s downstream target antioxidant proteins, Gclm and NQO1, were also observed by 
immunoblotting. Both proteins are increased, as expected, when Keap1 is knocked down 







Figure 4.3 Nrf2 is important in the survival of MCF7 cells during glucose 
deprivation. (A & B)MCF7shRNA cells were cultured in complete or glucose free 
media for 1 or 3 days. Cells were replenished with complete media and allowed to grow 
until colonies are visible. Nrf2shRNA cells have impaired survival during glucose 














Figure 4.4 Both autophagy competent and autophagy deficient cells have decreased 
survival when treated with an Nrf2 inhibitor. Cells were grown in complete or glucose 
free media with or without 2uM of the Nrf2 Inhibitor, ML-385, for 3 days. After 3 days, 
cells were replenished with complete media with no drug and allowed to grow until 















Figure 4.5 Nrf2 regulates protection from reactive oxygen species (ROS) produced 
during autophagy. (A) Time-dependent increases in levels of ROS during glucose 
deprivation, as measured using the DCFDA fluorescent probe.  When compared to 
control cultures (GFP shRNA), Keap1 knock-down resulted in modestly decreased levels 
of ROS as measured after 12 and 24 hours of glucose deprivation (p=0.02 at 12 hr, 
p=0.45 at 24 hr). Nrf2 knock down resulted in significantly higher levels of ROS after 
glucose deprivation (p=0.0018 at 12 hr, p=0.0014 at 24 hr).  (B) Incubation of cultures 
with glutathione (GSH) or N-acetyl cysteine (NAC) increases cell survival during 
glucose deprivation, especially in cells with knock-down of Nrf2.  All cultures were 
incubated for 3 days in glucose free media with or without antioxidants, followed by 
incubation in complete media for an additional 10 days to allow colony growth from 










Figure 4.6 Nrf2 is upregulated despite blocking the completion of autophagy. Cells 
were grown in complete or glucose free media for 48 or 72 hours with or without 25uM 
















Figure 4.7 Supplementing glucose free media with NAC does not prevent decreases 
in p62 or upregulation of Nrf2.  Cells were grown in glucose free or complete media 
with or without 2mM NAC for 48 hours. P62 and Nrf2 were assayed by immunoblot.  
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Hypoxia is another common stressor that cancer cells encounter and usually in the 
same areas as glucose deprivation would occur due to poor vasculature (51). As discussed 
in chapter 4, Nrf2 is important for survival of breast cancer cells during glucose 
deprivation so hypoxia was considered as another stressor in which Nrf2 might have a 
role. Furthermore, there is some evidence as discussed by Chun et al. that reactive 
oxygen species may affect the stabilization of HIF1α and as presented in background, 
Nrf2 is relevant in the antioxidant response. The data on ROS and stabilization of HIF1α 
is inconclusive as some data show HIF1α stabilization with decreased ROS whereas other 
studies show increased ROS cause HIF1α stabilization (78-81).  
In this chapter I’ll describe how breast cancer cells survive hypoxic conditions 
and that Nrf2 plays a role in the survival of hypoxic cells. Hypoxia in cells grown in 
complete media show increased antioxidant protein expression compared to normoxia. 
However, when glucose deprivation and hypoxia are combined, autophagy and Nrf2 
signaling is attenuated. These studies are not all encompassing but provide preliminary 














5.2 MATERIALS AND METHODS 
 
5.2.1 Cell Culture 
 
Human cancer cell line MCF7 was cultured in DMEM media (Gibco) supplemented with 
10% fetal bovine serum (FBS) (Gibco). T47D was cultured in RPMI (Gibco) 
supplemented with 10% FBS. Experiments requiring glucose deprivation used RPMI 
glucose free media (Gibco) 0.1%FBS. DMEM glucose free media was made from DME 
base (Sigma Aldrich) dissolved in ultrapure water and supplemented with sodium 
bicarbonate, sodium pyruvate, L-glutamine and 0.1%FBS. MCF7shRNA cells were 




Primary antibodies for NQO1 were purchased from Cell Signaling Technology. LC3B 
and GCLM were purchased from Novus Biologicals. HIF1α and Nrf2 antibodies were 
purchased from Santa Cruz. Anti-Actin antibody was purchased from Sigma-Aldrich.  
Anti-rabbit and anti-mouse secondary antibodies were purchased from Cell Signaling 
Technology. Puromycin was purchased from Sigma and dissolved in ultrapure water to 
make a 1mg/ml stock solution.  
 
5.2.3 Clonogenic Assays 
 
MCF7 cells were plated at appropriate density ranging from 500 to 3000 cells per well. 
After 24 hours incubation, cells were treated with complete or glucose free medium for 
variable amounts of time with the most common being 72 hours. Cells were incubated in 
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either normoxic or hypoxic (1% oxygen) conditions. After treatment with the different 
mediums and oxygen levels, cells were replenished with complete media without drug 
and allowed to grow in normoxic conditions for an average time of 10 days before being 




After experimental treatment, cells were harvested in TNE lysis buffer plus protease 
inhibitor and protein concentration was determined using Pierce BCA assay  (Thermo 
Fisher Scientific). Equal amounts of protein were loaded for each sample, separated by 
SDS-PAGE on a 10% or 10-20% gel Tris-HCl gel (Bio-Rad) and incubated overnight 
with primary antibody at 4ºC. Most antibodies were incubated at a 1:1000 concentration. 
Exceptions include actin (1:20,000), and sigma antibodies (1:500). After washing and a 
1.5 hour incubation with anti-rabbit or anti-mouse secondary antibody at room 
temperature, membranes were developed with SuperSignal West Femto Max Sensitivity 
Substrate( Thermo Fisher Scientific). Some membranes were stripped with Stripping 




The hypoxic atmosphere was produced by filling a glove box (Plas Labs Basic Glove 
Box 818-GB) with nitrogen until the atmosphere reached 1% oxygen as indicated by the 
gas sensor, Drager Pac 7000. A small incubator was put in the glove box and humidity 





5.3.1 Breast cancer cells are capable of surviving hypoxic conditions.  
 
As discussed above, breast cancer cells are able to survive glucose deprivation for 
approximately 3 days. Tumors exhibit areas of both nutrient deprivation and hypoxia and 
these factors may be important in how a cancer cell acts in the tumor microenvironment 
and reacts to drug. Therefore, I decided to study how hypoxia affects breast cancer cells. 
Figure 5.1 shows cells cultured in glucose free media and hypoxia and then replenished 
with complete media are able to proliferate. Establishing cell viability during hypoxia led 
to further inquiries into the behavior of cells with different levels of Nrf2 signaling.  
 
5.3.2 Nrf2 is important in determining survival of breast cancer cells in 
hypoxia.  
 
Nrf2 was shown to be important in survival of breast cancer cells during glucose 
deprivation in chapter 4. In addition to studying Nrf2 signaling in glucose deprivation, I 
wanted to study its effect during hypoxia.  When subjected to hypoxia alone, there is less 
cell growth than in normoxic conditions and as in glucose deprivation, Nrf2shRNA cells 
had impaired survival compared to control. Surprisingly, in Figure 5.2, hypoxia has no 
additive effect on cell death when cells are grown in glucose free media. Survival is again 
poorest for Nrf2shRNA cells but in all shRNA cases, hypoxia does not increase the 
amount of cell killing in cells grown in glucose deprived conditions.  
5.3.3 Hypoxia attenuates the response to glucose deprivation 
 
As seen in chapter 3 and 4, glucose deprivation induces autophagy and increases 
Nrf2 signaling. Figure 5.3 shows similar results with increased LC3II and Gclm when 
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MCF7shRNA are cultured in glucose free conditions. Compared to complete media, 
normoxic conditions, in the complete media, hypoxic setting, autophagy seems to be 
unchanged while Nrf2 signaling may be increased (Fig 5.3).  When combining the 
conditions of glucose deprivation and hypoxia, autophagy is attenuated and there’s a 
decrease in Nrf2 signaling. Interestingly HIF1α expression is also attenuated when cells 




































As with glucose deprivation, hypoxia is a metabolic stressor that cancer cells 
encounter within their tumor microenvironment. I was able to show that breast cancer 
cells are able to resume proliferation after a hypoxic stressor. While Nrf2shRNA was 
expected to have the most impaired survival in hypoxic conditions, it was unexpected that 
hypoxia and glucose deprivation do not have a synergistic effect on cell death. It seems 
that the predominate stressor, glucose deprivation, dictates the survival and death 
pathways that are activated and/or inhibited. This is corroborated by the finding that 
HIF1α expression was attenuated in the hypoxia/glucose deprivation combination growth 
conditions. According to several studies, this decrease in HIF1α might be due to 
decreases in ATP levels (52-54). Because glucose deprivation and hypoxia occur in the 
same areas of the tumor microenvironment, it is crucial to study their effects on cancer 
























































Figure 5.1 Cells are able to survive hypoxic conditions. MCF7 and T47D cells were 
culture in complete or glucose free media and in normoxic or hypoxic (1% oxygen) 
conditions for 48 hours. Cells were then stained with crystal violet or replenished with 






















Figure 5.2 Nrf2 is important in cell survival during hypoxia. MCF7shRNA cells were 
cultured in complete or glucose free media and placed in either a normoxic or hypoxic 
(1% oxygen) incubator for 72 hours. Cells were then replenished with complete media 
and allowed to grow in normoxic conditions until colonies were visible at which time, 






















Figure 5.3 Hypoxia attenuates the cell’s response to glucose deprivation. 
MCF7shRNA cells were cultured in complete or glucose free media in a normoxic or 
hypoxic (1% oxygen) incubator for 2 days. The following proteins were assessed by 
immunoblot: HIF1α, LC3, Nrf2, NQO1, and Gclm. (L= MCF7 lucshRNA, N= MCF7 
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Early in my graduate career, during a lab meeting we were discussing the topics 
of HER2 positive breast cancers and autophagy when an idea came to me that perhaps 
autophagy, a process that degrades macromolecules and proteins, might be degrading 
human epidermal growth factor receptor 2 and estrogen receptor of HER2 and ER 
positive cancer cells causing resistance to targeted drug therapies. At that time I had no 
preliminary data or knowledge to back up this hypothesis. With further research into drug 
resistance and autophagy, there was a possibility that this hypothesis may have a basis to 
it.  
Qadir Ma et al conducted a study in which autophagy was found to be increased 
in cells undergoing treatment with tamoxifen and that inhibition of autophagy could 
sensitize cells to the drug (59). Another investigator found that HER2 levels were 
decreased in trastuzumab resistant cells when maintained in drug (62).  
As it turns out and you will see described in this chapter, receptors of these two subtypes 
of breast cancer are downregulated during glucose deprivation. However, autophagy does 
not seem to be the mechanism of down-regulation. Additional studies were performed to 
determine the mechanism of downregulation along with experiments aimed at 
determining the efficacy of targeted drugs in the glucose deprived cells. Interestingly, 
despite receptor downregulation, targeted drugs were effective in the glucose deprivation 





6.2 MATERIALS AND METHODS 
 
6.2.1 Cell Culture 
 
Human cancer cell lines MCF7 and BT474 were cultured in DMEM media (Gibco) 
supplemented with 10% fetal bovine serum (FBS) (Gibco). T47D and SKBR3 were 
cultured in RPMI (Gibco) supplemented with 10% FBS. Experiments requiring glucose 
deprivation used RPMI glucose free media (Gibco) 0.1%FBS. DMEM glucose free 
media was made from DME base (Sigma Aldrich) dissolved in ultrapure water and 




Primary antibodies for HER2 were purchased from Cell Signaling Technology. HIF1α 
and ER (estrogen receptor) antibodies were purchased from Santa Cruz. Anti-Actin 
antibody was purchased from Sigma-Aldrich.  Anti-rabbit and anti-mouse secondary 
antibodies were purchased from Cell Signaling Technology. Chloroquine, a 
pharmacological inhibitor of autophagy, was dissolved in water to make a 25mM stock 
concentration. Rapamycin was diluted in water to make a 27uM stock solution. Lapatinib 
was purchased from LC Laboratories and dissolved in DMSO for a 200mg/ml stock 
solution. Trastuzumab/Herceptin was kindly provided by Genetech and a 1mg/ml stock 
solution was made. 4-hydroxytamoxifen was purchased from Sigma and dissolved in 
ethanol to make a 5mM solution. Tamoxifen was purchased from Sigma and dissolved in 
DMSO to make a 10mM stock solution. Bortezomib was dissolved in DMSO for a 1mM 
stock solution.  
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6.2.3 Clonogenic Assays 
 
MCF7 and T47D were plated at appropriate density ranging from 500 to 3000 cells per 
well. After 24 hours incubation, cells were treated with complete or glucose free medium 
for variable amounts of time with the most common being 72 hours. In other 
experiments, cells were treated with complete or glucose free media long with variable 
concentrations of chloroquine, 1uM 4OHT, 1uM tamoxifen, 1mM lapatinib, or 1ug/ml 
trastuzumab according to the experiment.  After treatment with the different mediums 
and drugs, cells were replenished with complete media without drug and allowed to grow 
for an average time of 10 days before being fixed with 100% methanol and stained with 




After experimental treatment, cells were harvested in TNE lysis buffer plus protease 
inhibitor and protein concentration was determined using Pierce BCA assay  (Thermo 
Fisher Scientific). Equal amounts of protein were loaded for each sample, separated by 
SDS-PAGE on a 10% or 10-20% gel Tris-HCl gel (Bio-Rad) and incubated overnight 
with primary antibody at 4ºC. Most antibodies were incubated at a 1:1000 concentration. 
Exceptions include actin (1:20,000), and sigma antibodies (1:500). After washing and a 
1.5 hour incubation with anti-rabbit or anti-mouse secondary antibody at room 
temperature, membranes were developed with SuperSignal West Femto Max Sensitivity 
Substrate( Thermo Fisher Scientific). Some membranes were stripped with Stripping 





Cells were harvested after 48 hours of growth in complete or glucose free media and 
RNA isolated with RNeasy Mini Kit (Qiagen) and eluted in water. RNA quality and 
concentration were measured by Nanodrop ND-1000 Spectrophotometer. The reverse 
transcription reaction was on a ThermoHybaid. The PCR reaction was performed on a 
ThermoHybaid. Samples were then run on a 1.3% agarose gel in TBE buffer and 
visualized using UV on a BioRad ChemiDoc System.  
 
 
Pre-RT mixture                                 7ul 
RNaisn (28U/ul)                            0.5ul 
MMLV (200U/ul)                           0.5ul 
Total RNA (3.5ug) + 
DEPC-water 
12ul 
 Total Volume= 20ul 
Table 6.2.1 Reverse transcription/cDNA synthesis reaction mixture 
 
 
5X RT buffer  400 ul 
100mM dATP 5ul 
100mM dTTP 5ul 
100mM dGTP 5ul 
100mM dCTP 5ul 
50pM Oligo d(T) 100ul 
DEPC-water 180ul 
 Total Volume= 
700ul 
Table 6.2.2 Pre-RT mixture for cDNA synthesis 
 
42ºC 60 minutes 
94ºC 5 minutes 




5X GoGreen Buffer (Promega 10ul 
Sense primer 0.25ul 
Antisense primer 0.25ul 
GoTaq Flexi DNA Polymerase (Promega) 0.25ul 
cDNA 3ul 
25mM MgCl2 5ul 
10mM dNTP  1ul 
DMSO 2.5ul 
dH20 27ul 
 Total Volume= 50ul 
Table 6.2.4 PCR reaction mixture 
 
1 cycle 94ºC for 1 minute 
23 cycles 94ºC for 30 seconds, 58ºC for 30 seconds, 
72ºC for 30 seconds 
1 cycle 72ºC for 5 minutes 
Hold 4ºC 
 















The hypoxic atmosphere was produced by filling a glove box (Plas Labs Basic Glove 
Box 818-GB) with nitrogen until the atmosphere reached 1% oxygen as indicated by the 
gas sensor, Drager Pac 7000. A small incubator was put in the glove box and humidity 





6.3.1 Breast Cancer Cells are Viable after 48 hours of glucose deprivation. 
 
Tumors are subject to areas of ischemia which include hypoxia and nutrient 
deprivation. To determine whether cancer cells are able to survive this stress, breast 
cancer cell lines were cultured in glucose free media for 48 hours and replenished with 
full media. As seen in Figure 6.1, cell lines SKBR3, BT474, MCF7, and T47D are able to 
survive and retain the ability to proliferate when nutrients are plentiful.  
6.3.2 Receptors are down-regulated in response to glucose deprivation.  
 
Resistance to targeted drug therapies is an important concept to study. Since its 
been shown that resistant cells benefit from inhibiting autophagy and that receptors in 
drug resistant cells have decreased growth factor receptors (59, 62),  I decided to study 
the effect of glucose deprivation on the drug target of HER2 and ER + cell lines. 
Surprisingly, both HER2+ and ER+ cell lines lose expression of HER2 and ER 
respectively during glucose deprivation and this loss is apparent even at 120 hours (Fig 
6.2). 
6.3.3 Response of breast cancer receptors to hypoxia.  
 
In addition to glucose deprivation occurring in tumors, so does hypoxia. 
Therefore, I decided to study the effect of hypoxia on the receptors of breast cancer to 
determine if it followed the discovery made during glucose deprivation. Cells cultured in 
complete media and hypoxia upregulate the protein HIF1α as expected. Unexpectedly, 
HER2 and ER are upregulated in hypoxic conditions compared to normoxia (Fig 6.3A). 
Another unanticipated observation was made when breast cancer cells were cultured in 
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glucose deprivation and hypoxic conditions. Glucose deprivation attenuated the HIF1α 
response while maintaining the down-regulation of receptors (Fig 6.3B)   
6.3.4 Autophagy, the proteasome, and decreased transcription as potential 
mechanisms of receptor downregulation 
 
Both autophagy and the proteasome are involved in degradation of proteins. 
Autophagy was studied first since the downregulation of receptors was occurring in a 
metabolic stress situation. Rapamycin induced autophagy showed no decrease in the 
estrogen receptor (Fig 6.4A). Time and dose response to rapamycin was also studied to 
ensure that estrogen receptor was not being degraded (Fig 6.4A and Fig 6.4B). 
Autophagy induced by glucose free media was also shown to not affect receptor levels. 
As seen in Figure 6.5 autophagy is induced, evidenced by the increase in LC3II in both 
glucose free cells and glucose free cells that have been replenished with complete media. 
However, estrogen receptor is present in the replenishment condition even though LC3II 
is present and autophagy is occurring. Also, chloroquine was used to block autophagy 
and as can be seen in the 48 hour glucose free conditions with chloroquine (Fig 6.5), 
estrogen receptor is still downregulated. Therefore autophagy could not be the 
mechanism of down-regulation. Because autophagy was ruled out as the mechanism of 
receptor downregulation, the proteasome was investigated next. Inhibition of the 
proteasome did not result in increased levels of HER2 or ER, therefore I concluded that 
proteasome degradation was unlikely to be the reason for receptor downregulation in 
glucose free conditions (Fig 6.6). A final mechanism of ER downregulation was 
assessed- mRNA expression of estrogen receptor was studied. As seen in Figure 6.7, 
glucose free media had low mRNA levels of estrogen receptor when compared to 
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complete media. This preliminary finding that reduced transcription may be the cause of 
receptor downregulation should be followed up.  
6.3.5 Drug efficacy of breast cancer cells during glucose deprivation. 
 
In addition to studying the mechanism of receptor downregulation in glucose 
deprivation, drug studies were performed to test their efficacy in glucose free media. 
Presumably a down regulation of the drug target would render the cell resistant. In fact, 
the opposite was discovered. Cells grown in glucose free media treated with drug actually 
had worse survival than cells grown in complete media and treated with drug (Fig 6.8). 
This is totally unexpected as discussed above, cells in glucose free media no longer have 
receptors whereas those in grown in complete media do. It should also be noted that 
estrogen receptor positive cells grown in complete media and treated with the HER2 
drug, trastuzumab, had significantly decreased survival even in comparison to the 
tamoxifen treated wells (Fig 6.9). And in another surprising result, this decrease in 




















The treatment of HER2 positive and ER positive breast cancers involves drugs 
targeted to growth factor receptors. The efficacy of such drugs is important to understand 
in the context of glucose deprivation as it’s a microenvironmental stressor present in 
tumors. In our studies, the receptors of the ER and HER2 positive breast cancer cell lines 
are downregulated during glucose deprivation. However, despite autophagy being 
induced in the glucose deprivation setting, it does not seem to be the mechanism of 
downregulation. Proteasome degradation was also found to be an unlikely mechanism. 
Preliminary studies on mRNA levels of estrogen receptor found that ER mRNA was 
decreased in glucose deprivation and this possible aspect of down regulation needs to be 
studied further. Knowing that receptors were downregulated in glucose deprivation, I was 
interested in seeing its effect on the efficacy of the targeted drugs to HER2 positive and 
ER positive cell lines. Quite interestingly drugs targeting ER and HER2 had more cell 
killing in the glucose deprivation setting compared to complete media. But without 
receptors to act on, how is this drug working? Tamoxifen is known to stabilize estrogen 
receptor (82) so perhaps tamoxifen also stabilizes receptors in glucose deprivation thus 
allowing killing of cells. A colleague suggested another idea that this decrease in 
receptors may be due to increased turnover, indicating increased activity of estrogen 
receptor, and thus blocking activity with tamoxifen would be catastrophic to these cells. 
More work needs to be done in order to determine how the drug is acting to kill cells 
without its target. Trastuzumab, a drug approved for breast cancer overexpressing HER2, 
has cell killing effects in ER positive breast cancer cells grown in complete media. Not 
only is the drug effective in that setting, but is less effective in ER positive breast cancer 
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cells grown in glucose free media.  The reason for this result also needs to be followed 
up. The beginning of this story of estrogen receptor and human epidermal growth factor 















































Figure 6.1 Breast cancer cells are viable after 48 hours of glucose deprivation. 
HER2+ and ER+ cell lines were cultured in glucose free media for 48 hours and stained. 
A second set of plates were stained after being replenished with complete media after the 










Figure 6.2 Receptors in HER2+ and ER+ cell lines are down-regulated in response 
to glucose deprivation. (A) SKBR3 cells were cultured in complete or glucose free 
media for 48 hours. Immunoblot was performed for HER2. (B) MCF7 cells were cultured 
in complete or glucose free media for 48 and 120 hours. Estrogen receptor was assayed 
by immunoblot. (C) T47D was grown in complete or glucose free media for 48 hours. 





Figure 6.3 Breast cancer cells in a hypoxic environment upregulate their receptors 
while glucose deprivation prevents HIF1α upregulation. (A) Cells were grown in 
complete media in either normoxic or hypoxic(1% oxygen) conditions. Cells were 
harvested at 48 and 144 hours. HIF1α and receptors were assayed by immunoblot. (B) 
Cells were cultured in complete or glucose free media in either normoxic or hypoxic 
conditions. Cells were harvested 48 hours later and assayed for HIF1α, HER2, and ER by 














Figure 6.4 Rapamycin induced autophagy does not reduce the expression level of 
estrogen receptor in T47D cells. (A) T47D cells were cultured in complete media and 
treated with increasing concentrations of rapamycin (1, 3, 10, 30, 100nM). At the 1nM 
concentration cells were treated for 24, 48, or 72. All other rapamycin concentrations 
were harvested at the 24 hour timepoint. ER was assayed by immunoblot. (B) T47D cells 
were grown in complete media and treated with 1nM rapamycin and harvested at varying 
















Figure 6.5 Glucose deprivation induced autophagy does not downregulate estrogen 
receptor. MCF7 cells were grown in complete or glucose free media with or without 
25uM chloroquine for 48 or 96 hours. Cells grown in glucose free media for 48 hours 
were replenished with complete media for an additional 48 hours. Estrogen receptor and 














Figure 6.6 Proteasome not responsible for the degradation of ER and HER2. (A) 
Breast cancer cell lines were grown in complete or glucose free media for 2 days. 
Bortezomib (1uM) was added to appropriate plates 4 hours before harvesting cells. HER2 
and ER were visualized by immunoblot. (B) T47D cells were grown in complete or 
glucose free media for 24 and 48 hours. Bortezomib (1.25 uM) was added 4 hours before 







Figure 6.7 Transcription of estrogen receptor is reduced during glucose deprivation. 
T47D cells were grown in complete or glucose free media for 2 days. Reverse 















Figure 6.8 Breast cancer cells grown in glucose free media are more sensitive to 
targeted therapies than those grown in complete media. Cells were grown in complete 
or glucose free media with or without 1uM 4-hydroxytamoxifen (4OHT), 1uM tamoxifen 
(Tam), 1mM lapatinib (Lap), or 1ug/ml trastuzumab (Tras) for 3 days and then 




Figure 6.9 Targeted drug therapies still have a killing effect despite absence of 
receptor. Breast cancer cells were grown in complete or glucose free media and treated 
with 1ug/ml of Trastuzumab (Tras) or 1uM of 4-hydroxytamoxifen (4OHT) for 3 days.  
Cells were replenished with complete media, allowed to grow, and then stained with 
crystal violet. ND=no drug 
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Chapter 7 Conclusions and Future Directions 
 
In our initial experiments, we found that cultured breast cancer cells (MCF7 and 
T47D cell lines) are capable of survival for approximately three days in the absence of 
glucose.  Glucose deprivation is common in ischemia, and we found that glucose 
deprivation results in an induction of autophagy, as evidenced by an increased LC3II: 
LC3 I ratio and punctate staining for LC3 II, which represent common markers of 
autophagy (83, 84).  Significantly, this autophagy response is critical for survival of these 
cells during glucose deprivation, and blocking autophagy with pharmacological agents 
such as chloroquine, or by knock-down of the essential autophagy genes ATG7 or 
Beclin1, results in rapid death by apoptosis when cells are cultured in glucose-free 
medium. 
Previous studies have not definitively defined the role of autophagy in glucose 
deprivation (64, 70, 85-87).  Several studies reported that knockdown of genes essential 
for autophagy in cells deprived of serum or amino acids was found to lead to cell death 
by apoptosis(65, 66), and  autophagy has also been shown to protect cells from 2-
deoxyglucose-induced cell death (68, 69, 88). While incubating cells with 2-
deoxyglucose might be expected to mimic the situation of glucose deprivation, 
experiments testing glucose-free medium in a variety of cultured cell lines, found no 
protective role for autophagy in the setting of glucose deprivation(70).   
The apparent discrepancy between these results from previous studies on glucose 
deprivation and the experiments reported here cannot be readily explained.  As detailed 
below, we did find that another survival pathway, activation of Nrf2, is also critical for 
survival of breast cancer cells deprived of glucose, and it is possible that previous 
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experiments used cells or conditions that did not result in activation of Nrf2.  Another 
possible explanation for discrepant results could be a result of some cancers being highly 
dependent on glutamine as a source of energy as well as biosynthetic substrates (89, 90), 
and for these cells, glucose deprivation might have different consequences on cell 
survival. 
The induction of autophagy and the protective effects of this process during 
glucose deprivation could be important for survival of cancer cells in situations of 
metabolic stress, such as ischemia.  In fact, substantial data points to autophagy 
contributing to cancer development in a variety of experimental settings(91). Particularly 
in cancers with RAS mutations, experimental data indicates that autophagy is critical for 
growth and survival of cancer cells (92-95).  In most cancerous tumors, the disordered 
microenvironment is associated with metabolic stress due to variable hypoxia and 
nutrient insufficiency, and in this setting autophagy appears to have an essential role in 
recycling intracellular macromolecules and organelles to transiently provide essential 
metabolic substrates in such settings(3).  Thus, our observations are consistent with breast 
cancer cells inducing autophagy as a protective response to glucose deprivation. 
I then investigated what protective molecular pathways might be triggered by 
autophagy in the setting of glucose deprivation.  In particular, my studies focused on p62, 
an LC3-interacting, ubiquitin-associated protein.  In various disease settings, p62 has 
been found to accumulate in cytosolic protein aggregates and in cellular inclusion bodies 
together with polyubiquitinated proteins. Autolysosomes containing p62- and LC3-
positive bodies are degraded by autophagy(74) , resulting in decreased levels of p62.  
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Interestingly, p62 has been shown to sequester and facilitate degradation of Keap-
1 protein, and when autolysosomes containing p62- and LC3-positive bodies are 
degraded by autophagy(74).  Consequently, in previous experiments reported 
independently by at least three laboratories, autophagy was found to result in reduced 
levels of p62(33, 46, 71).  Depleted levels of p62 in turn would be expected to allow 
Keap1 to bind the Nrf2 transcription factor and lead to increased degradation of Nrf2 
protein.   
As expected, I did find that p62 levels decrease in breast cancer cells during 
glucose deprivation.  Surprisingly, however, I found that Nrf2 protein levels and Nrf2 
activity are actually increased in the setting of glucose deprivation, which is an 
unexpected finding in light of previously reported findings that decreases in p62 lead to 
decreases in Nrf2.  These increases in Nrf2 protein levels and activity were not dependent 
on autophagy, since Nrf2 increased even in cells with knock-out of the ATG7 or Beclin1 
autophagy genes.  Furthermore, even though the Nrf2 pathway can be activated by 
oxidative stress (77), I found no evidence that increases in levels of Nrf2 are a response 
to increased levels of reactive oxygen species (ROS) during glucose deprivation.  Rather, 
I found that Nrf2 levels increase in breast cancer cells during glucose deprivation, even 
when cultures that were treated with the antioxidant, N-acetyl cysteine.  As summarized 
in the figure below, our experimental data shows that decreases in p62 do not lead to 
decreased levels of Nrf2.  Rather, levels of Nrf2 are increased.  Even though levels of 
ROS are also increased, and increased levels of ROS are capable of increasing Nrf2, our 
data suggests that these increases in ROS are not driving the increases in Nrf2. Therefore, 
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Figure 7.1 Schematic of the effect of glucose deprivation on Nrf2 signaling 
 
An important question to address in future studies, is how is Nrf2 activated by 
glucose deprivation?   Previous experiments have shown that Nrf2 pathway can be 
activated by various transcriptional, epigenetic, and post-translational mechanisms(96).   
Rather than focusing on mechanisms that cause increased Nrf2 activity during 
glucose deprivation, I directed additional studies to investigate what role the Nrf2 
pathway might play in cell survival during glucose deprivation.  Comparing cell survival 
in MCF7 cells that had been transfected with shRNA targeting KEAP1 (to increase Nrf2) 
or targeting Nrf2 (to decrease levels of this transcript), I found that loss of Nrf2 led to 
markedly decreased survival in glucose-deprived cultures.  Thus, in addition to 
autophagy, induction of Nrf2 is critical for cell survival in the setting of glucose 
deprivation.  Knock-down of Keap1 had minimal effects on survival in these 
experiments, likely because levels of Nrf2 were already elevated in glucose-deprived 
cells, and knock-down of Keap1 had minimal additional protective effect. 
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Nrf2 is a transcription factor known to activate multiple enzymes with antioxidant 
properties, including NADPH dehydrogenase quinone 1 (NQO1).  We found that 
increased Nrf2 levels correlated with increased levels of NQO1, indicating that Nrf2 
activity, as well as the level of Nrf2 protein, is increased during glucose deprivation.  To 
explore how glucose deprivation and Nrf2 activity affect cellular levels of ROS, we used 
2',7'-dichlorodihydrofluorescein diacetate (DCFDA), a cell-permeable, chemically 
reduced form of fluorescein, as an indicator for ROS in cells and found that cells with 
knockdown of Nrf2 showed time-dependent increases in ROS when cultured in glucose-
free medium.  By contrast, cells with knockdown of Keap1 showed significantly less 
ROS when cultured in glucose-free medium.  These results show that cellular levels of 
ROS are increased during glucose deprivation, and that Nrf2 is important for attenuating 
this oxidative stress. 
Since these data point to Nrf2 activity playing a critical role for cell survival 
during nutrient deprivation-induced autophagy, I then tested whether the antioxidants, N-
acetyl cysteine and glutathione, could also protect cell survival during autophagy.  
Indeed, these two antioxidants protect survival of Nrf2-depleted cells experiencing 
glucose deprivation, suggesting that the role of increased Nrf2 during glucose deprivation 
involves coordinating an anti-oxidant response. However, N-acetyl cysteine does not 
affect the decreases in p62 or the increases in Nrf2 levels during glucose deprivation, 
suggesting that neither of these processes are initiated by high levels of reactive oxygen 
species. 
In addition to studying the role of Nrf2 in the survival of cancer cells during 
glucose deprivation, I briefly looked at survival in hypoxia. Nrf2 was shown to be 
 100 
important in survival of hypoxic cells although to a lesser extent than in glucose 
deprivation. Studying the effect of combining hypoxia and glucose deprivation resulted in 
the finding that both the autophagic and antioxidant pathways were decreased. HIF1α 
expression was also attenuated in the hypoxia/glucose deprivation combination growth 
condition which may result from decreases in ATP levels according to some studies (52-
54).  
Finally in experiments unrelated to Nrf2, the effect of glucose deprivation on 
breast cancer receptors targeted by drugs was investigated. Breast cancer can be divided 
into 3 main categories based on receptor status with 2 of those subtypes- ER/PR positive 
and HER2 positive- having therapies targeted toward the estrogen receptor (ER) and 
human epidermal growth factor receptor 2 (HER2). Both tamoxifen and trastuzumab bind 
to ER and HER2 respectively and block signaling resulting in decreased growth. Initial 
response to the targeted therapy eventually turns to resistance. Therefore, I wanted to 
study how glucose deprivation, autophagy, and receptor downregulation might be 
involved in the drug resistance. I found that ER and HER2 are downregulated in glucose 
deprivation possibly through a transcriptional mechanism. Hypoxia alone had no effect 
on the receptors, however in combination with glucose deprivation, the receptors 
remained decreased. Both autophagy and proteasomal degradation of the receptors 
proved not to be the likely mechanism for downregulation as neither affected the levels of 
receptors when inhibited. With the finding that receptors were downregulated, it was 
interesting to see that the targeted drug therapies were still efficacious during glucose 
deprivation. In my studies, they were even better at cell killing than in complete media.  
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This is very paradoxical as the target receptor is present in the complete media cells and 
therefore the drug has its place to act on. In glucose free media the receptor is no longer 
present and thus the drug should not have a mode of action. Therefore it would be 
interesting to study the mechanism of action during glucose deprivation. In addition to 
tamoxifen having an unexpected effect, trastuzumab was found to be efficacious in 
estrogen receptor positive cell lines despite its use in the treatment of HER2 positive 
cancers.  
In summary, glucose deprivation is a situation commonly encountered by cancer 
cells, particularly in tumors with disordered tissue architecture and areas of cellular 
ischemia.  Glucose deprivation is not necessarily lethal to these cells because of 
protective mechanisms, which we have investigated due to their potential importance in 
understanding barriers to successful cancer treatment.  I identified two major mechanisms 
of cell survival in the setting of glucose deprivation: autophagy and induction of Nrf2.  
Interestingly, these two survival mechanisms appear to be activated independently of one 
another, and in fact, the activation of the Nrf2 pathway that we observed is contrary to 
expectations, based on previous studies that have investigated connections between 
autophagy and Nrf2.  Nrf2 was also found to be important in hypoxia. In unrelated 
studies to Nrf2, both estrogen and human epidermal growth factor receptors were 
discovered to be downregulated in response to glucose deprivation perhaps through a 
translational mechanism. Despite this downregulation of ER in MCF7 and T47D cells, 4-
hydroxytamoxifen was still efficacious. Major questions that should be addressed in 
future studies include, a) what are molecular mechanisms of Nrf2 activation during 
glucose deprivation?, b) can the cell survival mechanisms activated by glucose 
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deprivation be targeted for improving cancer therapy?,  c) to what extent are these 
survival mechanisms more critical for survival of cancerous cells in tumors than cells in 
normal tissues?, and finally in relation to targeted therapies, d) what drives the 
downregulation of receptors in breast cancer, why are targeted therapies still effective in 
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